INTREPID POTASH INC (IPI)

US46121Y2019 - Common Stock

19.7  -0.08 (-0.4%)

After market: 19.7 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IPI. IPI was compared to 85 industry peers in the Chemicals industry. The financial health of IPI is average, but there are quite some concerns on its profitability. IPI has a expensive valuation and it also scores bad on growth.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

IPI had negative earnings in the past year.
IPI had a positive operating cash flow in the past year.
In multiple years IPI reported negative net income over the last 5 years.
In the past 5 years IPI always reported a positive cash flow from operatings.

1.2 Ratios

IPI's Return On Assets of -4.64% is on the low side compared to the rest of the industry. IPI is outperformed by 76.47% of its industry peers.
The Return On Equity of IPI (-5.21%) is worse than 71.76% of its industry peers.
With a Return On Invested Capital value of 0.02%, IPI is not doing good in the industry: 72.94% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for IPI is below the industry average of 7.47%.
The last Return On Invested Capital (0.02%) for IPI is well below the 3 year average (4.52%), which needs to be investigated, but indicates that IPI had better years and this may not be a problem.
Industry RankSector Rank
ROA -4.64%
ROE -5.21%
ROIC 0.02%
ROA(3y)12.34%
ROA(5y)6.89%
ROE(3y)14.18%
ROE(5y)7.81%
ROIC(3y)4.52%
ROIC(5y)N/A

1.3 Margins

IPI's Operating Margin of 0.06% is on the low side compared to the rest of the industry. IPI is outperformed by 72.94% of its industry peers.
In the last couple of years the Operating Margin of IPI has declined.
IPI has a Gross Margin of 13.23%. This is in the lower half of the industry: IPI underperforms 75.29% of its industry peers.
IPI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.06%
PM (TTM) N/A
GM 13.23%
OM growth 3YN/A
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.3%
GM growth 5Y-6.41%

More info and screens

4

2. Health

2.1 Basic Checks

IPI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for IPI has been increased compared to 1 year ago.
IPI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IPI has a worse debt to assets ratio.

2.2 Solvency

IPI has an Altman-Z score of 2.48. This is not the best score and indicates that IPI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IPI (2.48) is better than 65.88% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that IPI is not too dependend on debt financing.
IPI's Debt to Equity ratio of 0.01 is amongst the best of the industry. IPI outperforms 94.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACC0
WACC9.26%

2.3 Liquidity

IPI has a Current Ratio of 3.27. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
IPI has a better Current ratio (3.27) than 81.18% of its industry peers.
A Quick Ratio of 0.81 indicates that IPI may have some problems paying its short term obligations.
IPI's Quick ratio of 0.81 is on the low side compared to the rest of the industry. IPI is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 0.81

More info and screens

1

3. Growth

3.1 Past

The earnings per share for IPI have decreased strongly by -104.04% in the last year.
Looking at the last year, IPI shows a very negative growth in Revenue. The Revenue has decreased by -17.34% in the last year.
The Revenue has been growing slightly by 6.03% on average over the past years.
EPS 1Y (TTM)-104.04%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-149.4%
Revenue 1Y (TTM)-17.34%
Revenue growth 3Y12.31%
Revenue growth 5Y6.03%
Revenue growth Q2Q-15.05%

3.2 Future

IPI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -36.17% yearly.
The Revenue is expected to decrease by -4.58% on average over the next years.
EPS Next Y-58.52%
EPS Next 2Y-40.64%
EPS Next 3Y-36.17%
EPS Next 5YN/A
Revenue Next Year-11.37%
Revenue Next 2Y-3.63%
Revenue Next 3Y-4.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPI. In the last year negative earnings were reported.
Also next year IPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IPI is valued cheaper than 83.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.54

4.3 Compensation for Growth

IPI's earnings are expected to decrease with -36.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-40.64%
EPS Next 3Y-36.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IPI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTREPID POTASH INC

NYSE:IPI (4/23/2024, 5:40:00 PM)

After market: 19.7 0 (0%)

19.7

-0.08 (-0.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap261.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.64%
ROE -5.21%
ROCE
ROIC
ROICexc
ROICexgc
OM 0.06%
PM (TTM) N/A
GM 13.23%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.27
Quick Ratio 0.81
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-104.04%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-58.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.34%
Revenue growth 3Y12.31%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y